Best Undervalued Stocks For 2018

I hate getting distracted by the thousands of other stocks out there. Because then things like GameStop Corp. (NYSE:GME) becoming an 8% yielding dividend stock — it may also be undervalued — happen.

GME stock has had a dizzying ride over the past 15 years, starting at $10 per share and reaching $62 at its peak in 2007, hitting a low of $16 in 2012, riding back up to $53 in 2013 and now sitting at $19 and falling. It has struggled because it has had to constantly morph to keep up with changes in gaming technology and platforms, and with competition. That has in turn required it to pivot and diversify into other offerings that have seen some limited success.

The gaming world is constantly in flux. That requires GME to hire employees who are able to be on the front lines of all the changes. Because GME stock derives a lot of revenues from its pre-owned game sales, employees must be experts in the areas of buy-sell-trade, pricing algorithms, inventory balancing, refurbishment capability, and consumer behavior.

Best Undervalued Stocks For 2018: Cambium Learning Group Inc.(ABCD)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Cambium Learning Group (NASDAQ:ABCD) Q1 2018 Earnings Conference CallMay. 14, 2018 9:00 a.m. ET

    Contents:
    Prepared Remarks Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 78.82 percent to close at $7.26 on Monday.
    GEE Group, Inc. (NYSE: JOB) shares jumped 18 percent to close at $2.36.
    McDermott International, Inc. (NYSE: MDR) climbed 15.7 percent to close at $7.00 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) gained 17.21 percent to close at $3.61.
    Stars Group Inc. (NASDAQ: TSG) rose 14.16 percent to close at $33.45. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares jumped 12.79 percent to close at $25.58.
    Nautilus, Inc. (NYSE: NLS) shares gained 11.52 percent to close at $15.00. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target.
    Box, Inc. (NYSE: BOX) rose 10.94 percent to close at $22.91.
    Insmed Incorporated (NASDAQ: INSM) shares rose 10.76 percent to close at $26.05. Credit Suisse upgraded Insmed from Neutral to Outperform.
    NextDecade Corporation (NASDAQ: NEXT) shares rose 10.02 percent to close at $6.48.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) shares gained 8.37 percent to close at $2.46 on Monday after falling 10.98 percent on Friday.
    Cambium Learning Group, Inc. (NASDAQ: ABCD) shares gained 7.81 percent to close at $11.11.
    Vectren Corporation (NYSE: VVC) shares rose 7.26 percent to close at $70.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash.
    Tennant Company (NYSE: TNC) rose 6.66 percent to close at $74.45 after the company posted upbeat Q1 results and raised its FY18 earnings outlook.
    Hanesbrands Inc.
  • [By Logan Wallace]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Cambium Learning Group alerts:

    WMMS teacher up for National History Day award (dailyprogress.com) ValuEngine Upgrades Cambium Learning Group (ABCD) to Buy (americanbankingnews.com) John F. Campbell Sells 20,809 Shares of Cambium Learning Group (ABCD) Stock (americanbankingnews.com) Cambium Learning Group to Announce First Quarter 2018 Financial Results (feeds.benzinga.com)

    Several brokerages have commented on ABCD. BidaskClub raised Cambium Learning Group from a “hold” rating to a “buy” rating in a research report on Saturday, January 13th. ValuEngine raised Cambium Learning Group from a “hold” rating to a “buy” rating in a research report on Wednesday, May 2nd. Finally, B. Riley assumed coverage on Cambium Learning Group in a research report on Thursday, March 29th. They issued a “buy” rating and a $12.50 price target for the company.

  • [By Lisa Levin] Gainers
    Valeritas Holdings, Inc. (NASDAQ: VLRX) shares jumped 17 percent to $3.65.
    Cambium Learning Group, Inc. (NASDAQ: ABCD) shares rose 13.5 percent to $11.70.
    McDermott International, Inc. (NYSE: MDR) gained 11.6 percent to $6.75 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.
    Nautilus, Inc. (NYSE: NLS) shares jumped 11.2 percent to $14.95. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target.
    GEE Group, Inc. (NYSE: JOB) shares gained 11 percent to $2.2199.
    Check-Cap Ltd. (NASDAQ: CHEK) surged 10.8 percent to $4.50.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) rose 10.1 percent to $3.39.
    Stars Group Inc. (NASDAQ: TSG) climbed 9.6 percent to $32.10. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion.
    Insmed Incorporated (NASDAQ: INSM) shares jumped 9.1 percent to $25.66. Credit Suisse upgraded Insmed from Neutral to Outperform.
    Tennant Company (NYSE: TNC) rose 8.4 percent to $75.65 after the company posted upbeat Q1 results and raised its FY18 earnings outlook.
    Command Security Corporation (NYSE: MOC) shares gained 6.4 percent to $3.0960 after the company disclosed a $23 million five-year contract with LaGuardia Gateway Partners for LaGuardia Airport New Central Terminal Building.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 6.2 percent to $2.41 after falling 10.98 percent on Friday.
    Vectren Corporation (NYSE: VVC) shares rose 5.7 percent to $69.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash.
    Hanesbrands Inc. (NYSE: HBI) gained 4.9 percent to $18.035. Stifel Nicolaus upgraded Hanesbrands from Hold to Buy.
    M

Best Undervalued Stocks For 2018: Brainstorm Cell Therapeutics Inc.(BCLI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

    Get Brainstorm Cell Therapeutics alerts:

    Brainstorm Cell Therapeutics (BCLI) Issues Quarterly Earnings Results, Beats Expectations By $0.20 EPS (americanbankingnews.com) BrainStorm Announces First Quarter 2018 Financial Results and Provides Corporate and Clinical Highlights (finance.yahoo.com) What analyst predict for Brainstorm Cell Therapeutics NASDAQ:BCLI ? (stockmarketdaily.co) Global Autologous Cell Therapy Market 2022: Market Size, Shares, Revenue, Production, Consumption (thetechnicalprogress.com) Hot Stocks to Observe: Forward Industries, Inc. (NASDAQ:FORD), Nordic American Tankers Limited (NYSE:NAT … (journalfinance.net)

    Shares of Brainstorm Cell Therapeutics traded up $0.12, hitting $3.76, during trading hours on Monday, according to MarketBeat. 1,552 shares of the stock were exchanged, compared to its average volume of 63,674. The company has a market cap of $69.42 million, a P/E ratio of -14.46 and a beta of 1.86. Brainstorm Cell Therapeutics has a one year low of $3.70 and a one year high of $3.85.

Best Undervalued Stocks For 2018: General Growth Properties, Inc.(GGP)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Shares of mall-focused REIT GGP (NYSE:GGP) have plunged in 2018. Initially, the stock price fell due to ongoing worries about the so-called “retail apocalypse” and its effect on mall occupancy and lease rates.

  • [By Adam Levine-Weinberg]

    In recent years, investors have become increasingly fearful about the so-called “death of the mall.” As a result, shares of top-tier mall REITs like Taubman Centers (NYSE:TCO), Simon Property Group (NYSE:SPG), GGP (NYSE:GGP), and Macerich (NYSE:MAC) have tended to trade at a discount to their net asset values (NAV), the underlying value of their assets.

  • [By Joseph Griffin]

    These are some of the news articles that may have effected Accern’s scoring:

    Get GGP alerts:

    Read This Before Trade: Facebook, Inc. (FB), GGP Inc. (GGP) (nmsunews.com) Ggp Inc (GGP)’s Weekly Performance of -0.90% Is Nothing to Write Home About (parkcitycaller.com) Is GGP Inc (NYSE:GGP) A Good Dividend Stock? (finance.yahoo.com) GGP (GGP) Downgraded by Zacks Investment Research to “Hold” (americanbankingnews.com) Dazzling Stocks: GGP Inc. (NYSE:GGP), Nielsen Holdings plc (NYSE:NLSN), AmerisourceBergen Corporation (NYSE … (thestreetpoint.com)

    GGP has been the subject of a number of recent research reports. Royal Bank of Canada restated a “buy” rating and set a $24.00 target price on shares of GGP in a research report on Monday, February 12th. Boenning Scattergood reissued a “buy” rating and issued a $35.00 target price on shares of GGP in a research note on Tuesday, March 27th. Mizuho raised GGP from a “neutral” rating to a “buy” rating and set a $24.00 target price for the company in a research note on Monday, March 19th. Zacks Investment Research upgraded GGP from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a report on Wednesday, April 11th. Finally, Barclays cut their price target on GGP from $24.00 to $23.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 30th. Three analysts have rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company’s stock. GGP currently has an average rating of “Hold” and a consensus price target of $24.92.